Sodium‐Glucose Cotransporter‐2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population‐Based Investigation

BACKGROUND: Whether the early use of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors have cardioprotective effects following acute myocardial infarction is unknown. Thus, we aimed to evaluate the association between the early initiation of SGLT2 inhibitors and cardiac event rates in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Osung, Myong, Jun‐Pyo, Lee, Yunhee, Choi, Yeon‐Jik, Yi, Jeong Eun, Seo, Suk Min, Jang, Sung‐Won, Kim, Pum Joon, Lee, Jung‐Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382092/
https://www.ncbi.nlm.nih.gov/pubmed/37421263
http://dx.doi.org/10.1161/JAHA.122.027824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382092/
https://www.ncbi.nlm.nih.gov/pubmed/37421263
http://dx.doi.org/10.1161/JAHA.122.027824

Ejemplares similares